Cardiovascular
1 drug is in development for Recurrent Pericarditis.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Recurrent Pericarditis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| vtx2735 | Ventyx Biosciences, Inc. (VTYX) |
About this indication
Recurrent Pericarditis context
Cardiovascular·MeSH: Pericarditis (D010493)
Frequently asked questions
How many drugs are in development for Recurrent Pericarditis?
BioSniper tracks 1 drug in development for Recurrent Pericarditis across 1 company.
How many clinical trials target Recurrent Pericarditis?
There are 6 clinical trials targeting Recurrent Pericarditis tracked by BioSniper.